ConductScience.org, home

Paper · 20537908

Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.

O'Reilly RJ and 4 others. Semin Immunol, 2010. Cited by 28 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation. Papers, record 20537908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20537908

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.
PubMed
Journal
Semin Immunol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2023-11-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1O'Reilly RJRichard J
2Dao TTao
3Koehne GGuenther
4Scheinberg DDavid
5Doubrovina EEkaterina

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adoptive TransferMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
ImmunotherapyMajor topic
LeukemiaMajor topic
T-LymphocytesMajor topic
Transplantation, HomologousMajor topic
Amino Acid Sequence
Animals
Clinical Trials as Topic
Epitopes, T-Lymphocyte
Humans
Mice
Molecular Sequence Data
Secondary Prevention
WT1 Proteins

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA023766NCI NIH HHSUnited StatesP01CA023766PubMed and NIHNIH RePORTER
P01 CA106450NCI NIH HHSUnited StatesP01CA106450PubMed and NIHNIH RePORTER
CA23766NCI NIH HHSUnited StatesP01CA023766PubMed and NIHNIH RePORTER
CA106450NCI NIH HHSUnited StatesP01CA106450PubMed and NIHNIH RePORTER

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05350163T-cell Receptor α/β Depleted Donor Lymphocyte InfusionBackground

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References176

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112,115,544Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers.Int J Cancer2002https://conductscience.org/library/papers/12115544PubMed
26,186,923A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease.Nature1983https://conductscience.org/library/papers/6186923PubMed
39,490,709Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.Blood1998https://conductscience.org/library/papers/9490709PubMed
412,473,218T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma.Cytotherapy2002https://conductscience.org/library/papers/12473218PubMed
53,310,002Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.Prog Clin Biol Res1987https://conductscience.org/library/papers/3310002PubMed
614,585,640Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.Lancet2003https://conductscience.org/library/papers/14585640PubMed
716,575,000High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.J Clin Oncol2006https://conductscience.org/library/papers/16575000PubMed
812,070,282Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells.J Exp Med2002https://conductscience.org/library/papers/12070282PubMed
912,969,970Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.Blood2004https://conductscience.org/library/papers/12969970PubMed
103,896,348Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts.Blood1985https://conductscience.org/library/papers/3896348PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
34,433,633Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer.J Immunother Cancer2021https://conductscience.org/library/papers/34433633PubMed
32,184,297Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.Cancer Immunol Res2020https://conductscience.org/library/papers/32184297PubMed
27,897,332Recent advances in T-cell immunotherapy for haematological malignancies.Br J Haematol2017https://conductscience.org/library/papers/27897332PubMed
27,479,183HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.Leukemia2017https://conductscience.org/library/papers/27479183PubMed
26,926,229Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS.Bone Marrow Transplant2016https://conductscience.org/library/papers/26926229PubMed
26,834,952Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic).Ther Adv Hematol2016https://conductscience.org/library/papers/26834952PubMed
26,648,070Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.Curr Drug Targets2017https://conductscience.org/library/papers/26648070PubMed
26,056,592Adoptive T-cell therapy for Leukemia.Mol Cell Ther2014https://conductscience.org/library/papers/26056592PubMed
26,034,113T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect.Haematologica2015https://conductscience.org/library/papers/26034113PubMed
25,987,253Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential.Leukemia2015https://conductscience.org/library/papers/25987253PubMed

1 to 10 of 16

See all 16 cited by

Genes40

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20537908

GET https://conductscience.org/api/papers/v1/20537908/references?page=2